TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06235021 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06235021 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05061940 — Safety Biomarker (SAF): Human leucocyte antigen
Study NCT05838586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05520723 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05960656 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04806815 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06041854 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05489276 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06385925 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05060003 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06485232 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06485232 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04823143 — Predictive Biomarker (PRD): VCP mRNA
Genes: VCP
Study NCT04932915 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05087940 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04647305 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05313243 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05049109 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04814056 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT05057247 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT06362720 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study NCT05622981 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05622981 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05622981 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05622981 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05386160 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06511453 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06388018 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06028490 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT04547777 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06202261 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06202261 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06360211 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06360211 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06360211 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06360211 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06547307 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT06547307 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study NCT05186506 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04786613 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06047678 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05536206 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04973423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06499038 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04417231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05987956 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04814602 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05813431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05220358 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06535529 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05164510 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05418621 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT04892654 — Surrogate Endpoint (SUR): Undetectable plasma HIV RNA
Study NCT06175624 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04697953 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04731259 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03674320 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03851081 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06216626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05743985 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05642572 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05642572 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05838092 — Predictive Biomarker (PRD): ABCB5 mRNA
Genes: ABCB5
Study NCT05490849 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study NCT06114797 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06121713 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT05198843 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05938127 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03626285 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06299202 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06299202 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03597594 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04817605 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT04974723 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04692467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06535126 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05015894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05810415 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05883852 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06262035 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05474391 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05899283 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06232447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06299462 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05333874 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05333874 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04975373 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04415853 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06349668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05679492 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05951023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06198946 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06421363 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06546540 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study NCT05037747 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05631067 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04840342 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT04940364 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT06457009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04885205 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05947448 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05253859 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05625932 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05625932 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05582941 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06043921 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06043921 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05406336 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06210165 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04740723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06258408 — Predictive Biomarker (PRD): FGFR4 mRNA
Genes: FGFR4; JTK2; TKF
Study NCT05323045 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04769245 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06006182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06006182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06006182 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05006326 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05891145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05352425 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05298176 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06574763 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05695859 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05695859 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06112210 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05271448 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06119152 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00028327 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06636617 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06635564 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06635616 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05776290 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05864404 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06111950 — Predictive Biomarker (PRD): RTTN mRNA
Genes: RTTN
Study NCT06464718 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06464718 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06536062 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04634357 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05651815 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06133634 — Predictive Biomarker (PRD): ASPRV1 mRNA
Genes: ASPRV1; SASP
Study NCT04922138 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06288113 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05215106 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05215106 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05039268 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04714398 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06016868 — Predictive Biomarker (PRD): ANXA2 mRNA
Genes: ANXA2; ANX2; ANX2L4; CAL1H; LPC2D
Study NCT06016868 — Predictive Biomarker (PRD): NDRG1 mRNA
Genes: NDRG1; CAP43; DRG1; RTP
Study NCT06016868 — Predictive Biomarker (PRD): STAT1 mRNA
Genes: STAT1
Study NCT05431504 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05431504 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06584266 — Predictive Biomarker (PRD): LAT mRNA
Genes: LAT
Study NCT05860036 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05683340 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06251999 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05573126 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05573126 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04475744 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04475744 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06232408 — Predictive Biomarker (PRD): PLK4 mRNA
Genes: PLK4; SAK; STK18
Study NCT05453188 — Predictive Biomarker (PRD): ACTN3 mRNA
Genes: ACTN3
Study NCT05453188 — Predictive Biomarker (PRD): AMPD1 mRNA
Genes: AMPD1
Study NCT05453188 — Predictive Biomarker (PRD): CKM mRNA
Genes: CKM; CKMM
Study NCT05453188 — Predictive Biomarker (PRD): MYLK3 mRNA
Genes: MYLK3; MLCK
Study NCT05453188 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT05453188 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06379945 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT04968067 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05712174 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06532682 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04916639 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04955977 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05271344 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04845425 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT04845425 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05581771 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04842981 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04842981 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT04842981 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT04842981 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT04842981 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04842981 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04842981 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05238883 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study NCT05512780 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05512780 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05512780 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04858295 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06431789 — Predictive Biomarker (PRD): SLCO1B1 mRNA
Genes: SLCO1B1; LST1; OATP1B1; OATP2; OATPC; SLC21A6
Study NCT00001112 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04869306 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06066151 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05365984 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05843942 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05633290 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06530316 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05736172 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05532605 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05909618 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05293236 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06137651 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04853615 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06294340 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06146478 — Predictive Biomarker (PRD): HBG2 mRNA
Genes: HBG2
Study NCT06146478 — Predictive Biomarker (PRD): BCL11A mRNA
Genes: BCL11A; CTIP1; EVI9; KIAA1809; ZNF856
Study NCT06146478 — Predictive Biomarker (PRD): MYB mRNA
Genes: MYB
Study NCT06146478 — Predictive Biomarker (PRD): KLF1 mRNA
Genes: KLF1; EKLF
Study NCT05091125 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06533982 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06478784 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06425120 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05570305 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05937503 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT05937503 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT06407531 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04887012 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04867109 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study NCT05931575 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05157646 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04554771 — Predictive Biomarker (PRD): ADAM12 mRNA
Genes: ADAM12; MLTN; UNQ346/PRO545
Study NCT04866901 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06572670 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06077903 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06077903 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06465342 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05669391 — Predictive Biomarker (PRD): DARS1 mRNA
Genes: DARS1; DARS; PIG40
Study NCT06035081 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study NCT01970124 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06077396 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04695327 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04695327 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05859490 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06371794 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT05994664 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study NCT05994664 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05177809 — Predictive Biomarker (PRD): RFC1 mRNA
Genes: RFC1; RFC140
Study NCT04572451 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05022303 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06145347 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT05663671 — Predictive Biomarker (PRD): DEFA5 mRNA
Genes: DEFA5; DEF5
Study NCT06418724 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05276375 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06086288 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05728268 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06491004 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study NCT05935787 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05623241 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06265519 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06265519 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04554888 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study NCT06445400 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06081777 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06081777 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05501470 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT06106477 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06106477 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06142617 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06142617 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06049368 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05194033 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03994627 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05508269 — Predictive Biomarker (PRD): ELAVL2 mRNA
Genes: ELAVL2; HUB
Study NCT05655923 — Predictive Biomarker (PRD): BMP2 mRNA
Genes: BMP2; BMP2A
Study NCT05525507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06755346 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT06245785 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT05275777 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05860621 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05696106 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2